Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03503617 · ClinicalTrials.gov registry record · NA

RehabTouch Home Therapy for Stroke Patients

A NA study of Cerebral Stroke, sponsored by Flint Rehabilitation Devices.

Completed
Registry status
NA
Development phase
27
Enrollment target
1
Study location

NCT03503617 is a NA study of Cerebral Stroke that has completed, run by Flint Rehabilitation Devices. The registered enrollment target is 27 participants, below the 10,161-participant average among 6 other Cerebral Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03503617, a NA study of Cerebral Stroke, has completed, sponsored by Flint Rehabilitation Devices.

COMPLETED
Registry status
NA
Development phase
27 participants
Enrollment target
1
Study location

Study Summary

We will investigate the efficacy of a newly developed exercise device (RehabTouch) for people in the subacute stage after a stroke compared to a traditional tabletop exercise program. RehabTouch uses embedded sensors that can track and record the patient's direction and degree of movement as they perform exercises described on a computer.

Conditions Studied

Interventions

  • DEVICE RehabTouch
  • OTHER Conventional tabletop exercise program

Study Locations (1)

California

  • Rancho Research Institute, Inc. - Downey

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2018-11-01
Est. Completion 2021-03-31
Phase NA

Sponsor

Flint Rehabilitation Devices

6 total trials

What the Registry Record Tells You About NCT03503617

The ClinicalTrials.gov registry entry for NCT03503617 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 10,161-participant average among 6 other Cerebral Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Flint Rehabilitation Devices, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cerebral Stroke appearing as the primary indexed condition, and to 2 interventions - of which RehabTouch is the first listed.

NCT03503617 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03503617 about?

NCT03503617 is a clinical study titled "RehabTouch Home Therapy for Stroke Patients". We will investigate the efficacy of a newly developed exercise device (RehabTouch) for people in the subacute stage after a stroke compared to a traditional tabletop exercise program. RehabTouch uses embedded sensors that can track and record the patient's direction and degree of movement as they pe...

What is the current status of trial NCT03503617?

This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2018-11-01. Estimated completion is 2021-03-31.

What conditions does trial NCT03503617 study?

This clinical trial studies the following conditions: Cerebral Stroke.

What interventions are being tested in trial NCT03503617?

The interventions under investigation include: RehabTouch (DEVICE), Conventional tabletop exercise program (OTHER).

Who is sponsoring clinical trial NCT03503617?

This trial is sponsored by Flint Rehabilitation Devices, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03503617 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cerebral Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.